North East and North Cumbria
ICS Formulary
ICS Formulary
6 Endocrine system
06-01-02-02 Biguanides
| Metformin |
|
Formulary
|
|
 MHRA Drug Safety Update (June 2022): Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk MHRA Drug Safety Update (Mar 2022): Metformin in pregnancy: study shows no safety concerns |
|
| Metformin 1g tablets; high cost oral solutions |
|
Non Formulary
|
1g tablets 1g/5ml oral solution sugar free 850mg/5ml oral solution sugar free
For preferred preparations, see main formulary entry above |
|
Links
- MHRA Drug Safety Update (June 2022): Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
- MHRA Drug Safety Update (Mar 2022): Metformin in pregnancy: study shows no safety concerns
- NICE NG 28: Type 2 diabetes in adults: management
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- North East and North Cumbria ICS - Medication Management of Type 2 Diabetes in Adults Guidelines
- NTAG Endocrine System Recommendations